Meningitis Diagnosis and Treatment Market Share

Meningitis Diagnosis and Treatment Market Overview

Meningitis Diagnosis & Treatment Market Size was valued at USD 0.19 Billion in 2023. The Global Meningitis Diagnosis & Treatment industry is projected to grow from USD 020 Billion in 2024 to USD 0.30 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.31% during the forecast period (2024 - 2032). The market of meningitis diagnosis and treatment is mainly driven by the growing prevalence of meningitis as well as the increasing efforts to combat the disease, including efforts to reduce the incidence of the disease as well as efforts to manage the disease better. The growing scope of the healthcare sector in emerging regions is likely to be a major market driver for the meningitis diagnosis and treatment report over the forecast period.

Competitive Analysis

Leading players in the market include B. Braun Melsungen AG, Sanofi, Pfizer Inc., Siemens Healthcare Private Limited, GlaxoSmithKline plc, Merck KGaA, Baxter, Abbott, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Quest Diagnostics Inc., Luminex Corporation, F. Hoffman-La Roche Ltd., Cepheid, and Pfizer Inc., hold dominant shares in the market.

• A study conducted at the University of Liverpool found in June 2018 that viruses are the most common cause of meningitis in the UK. Such studies are likely to be important for the growth of the meningitis diagnosis and treatment industry over the forecast period.


• In February 2019, researchers from the Pediatric Emergency Care Applied Research Network developed a new protocol that allows doctors to rule out the worst possibilities in patients below the age of 2 months, which eliminates the need for spinal tap procedures and antibiotics treatments, which can prove troublesome for the immune system of newborns.

Market Dynamics

The growing prevalence of viral and bacterial meningitis is likely to be a major driver for the meningitis diagnosis and treatment market over the forecast period. Meningitis is a pathogenic inflammation that affects the brain and spinal cord and can result in symptoms such as neck pain, fever, and headache. The disease can be fatal if allowed to develop and timely intervention is needed to keep the disease in check. The growing prevalence of pathogenic infections is likely to be a key market driver for the meningitis diagnosis and treatment over the forecast period.

The rising demand for point of care diagnostic services, especially for chronic diseases, is also likely to be a major driver for the growth of market over the forecast period.

On the other hand, the lack of awareness about meningitis in developing regions and the possibility of harmful side effects of antibiotics are likely to hold back the market growth over the forecast period.

Segmentation

The meningitis diagnosis and treatment market is segmented on the basis of disease type, service, end user, and region.

The market segment of meningitis diagnosis and treatment, By disease type bacterial meningitis, viral meningitis, fungal meningitis, and others. Both viral and bacterial meningitis segments accounted for more than 40% of the meningitis diagnosis and treatment market in 2017 and are likely to dominate the meningitis diagnosis and treatment industry over the forecast period. The viral meningitis segment accounted for the largest market share of the meningitis diagnosis and treatment market in 2017.

By Treatment and Diagnosis the market is segmented into diagnosis, treatment. The treatment segment is sub-segmented into antibiotics, steroids, antifungal drugs, and others, while the diagnosis segment is subdivided into blood tests, imaging, lumbar puncture, and others. Treatment accounted for a larger share in the of meningitis diagnosis and treatment, and is expected to grow at the highest CAGR over the forecast period.

The market segment of meningitis diagnosis and treatment, By end user are hospitals & clinics, diagnostic centers, and others. The hospitals and clinics segment accounted for the largest market share of the meningitis diagnosis and treatment market. The segment is also expected to exhibit the fastest CAGR over the forecast period due to the growing demand for advanced meningitis diagnosis and treatment procedures in hospitals and clinics.

Regional Analysis

The Americas and Europe segments dominate the meningitis diagnosis and treatment market, holding first and second place in the global market, respectively. Moreover, Asia Pacific accounts for a significant market share of meningitis diagnosis and treatment. Also, the Asia Pacific market is expected to exhibit the highest CAGR of 4.07% over the forecast period due to the growing awareness about meningitis and the growing financial capacity of the healthcare sector in the region.

Market of Meningitis Diagnosis and Treatment, by Region

• Americas




• North America




• US


• Canada




• Latin America




• Europe




• Western Europe




• Germany


• France


• Italy


• Spain


• UK


• Rest of Western Europe




• Eastern Europe




• Asia-Pacific




• Japan


• China


• India


• Australia


• South Korea


• Rest of Asia-Pacific




• The Middle East & Africa




• Middle East


• Africa